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Insulin Resistance Heralds Positive Cultures
after Severe Injury
Nathan T. Mowery,1 Randy J. Carnevale,2 Oliver L. Gunter,4 Patrick R. Norris,1 Lesly A. Dossett,1
Marcus J. Dortch,3 John A. Morris, Jr.,1 and Addison K. May1
Abstract
Background: Insulin resistance and hyperglycemia are common in acutely injured patients, and associated with
poor outcomes. In the era of tight glucose control, measures of insulin responsiveness (IR) may provide a better
indicator of patient status than does the serum glucose concentration. We hypothesized that measures of IR
during tight glycemic control protocols are associated with infection and may be more predictive than the serum
glucose concentration.
Methods: All critically injured, mechanically ventilated patients undergo protocolized tight glycemic control
with the aid of a computer-based system that calculates the insulin dose using an adapting multiplier (insulin
dose¼ [blood glucose – 60)M). Consecutive patients on protocol were studied to identify the incidence of
positive sterile-site or quantitative bronchoalveolar lavage cultures (>104 colony-forming units=mL). Patients
were stratified by presence and number of positive cultures and analyzed by both serum glucose measures and
measures of IR (average multiplier and average insulin infusion rate).
Results: During the six-month study period, 356 patients were placed on the tight glycemic control protocol.
Of these, 101 patients had 192 positive cultures. Patients with positive cultures required significantly more
hourly insulin than those without a positive culture (3.7 vs. 2.8 units=h; p¼<0.001). Logistic regression showed
the insulin dose (odds ratio 2.1; 95% confidence interval 1.6, 3.0; p¼<0.001) and the adapting multiplier to be
independent predictors of the patient having a positive culture among other factors associated with nosocomial
infection.
Conclusions: Insulin resistance, quantified by hourly insulin dose and median multiplier, confers a higher risk of
systemic nosocomial infection. Patients with positive cultures actually had lower admission and median blood
glucose values over their intensive care unit stays, highlighting the decreased value of this measure as a
predictor of outcome in the setting of tight glucose control. A greater insulin requirement suggesting resistance
may be used as a marker of a higher risk of nosocomial infection.
Admission hyperglycemia is a known predictor of deathin the trauma population [1,2]. Hyperglycemia at ad-
mission and throughout the patient’s hospital stay also cor-
relates significantly with infective complications [3]. An
increase in the blood glucose concentration precedes positive
cultures [4]. However, as intensive insulin regimens become
more effective, distinguishing patients on the basis of clini-
cally significant differences in blood glucose concentration
becomes more challenging. The aggressive management of
both hypoglycemia and hyperglycemia makes them poor
predictors of outcomes. An individual’s response to the ini-
tiation of tight glucose control and the response to insulin as a
drug provide one method to differentiate these patients.
Persistence of untreated hyperglycemia during the pa-
tient’s hospitalization leads to adverse outcomes [5]. Un-
fortunately, the risk of hypoglycemia and the lack of
widespread infrastructure to implement tight glucose control
have limited its use in the trauma population. When insti-
tuted, protocols have used more liberal goals (80–150 mg=dL)
instead of the more widely accepted glucose range (80–
110 mg=dL), which have been demonstrated to be effective in
other populations. A few studies have had mixed results in
applying tight glucose control to the trauma population [6,7].
Although the question of whether hyperglycemia after
trauma is an adaptive mechanism or a pathologic response
to stress remains, an increasing body of literature suggests
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that the aggressive management of glucose leads to better
outcomes [8–12]. These studies have been questioned be-
cause of conflicting data [13], but tight glucose control re-
mains the standard in the intensive care setting around the
world.
We sought to compare persistent hyperglycemia with es-
calating insulin dose as a means of identifying patients at risk
for infective complications. We developed a computer-based
decision support system to assist in the maintenance of eu-
glycemia in critically patients that captures all glucose values,
insulin doses, and a mathematical multiplier (M) to determine
the insulin dose for each patient. We hypothesized that insulin
dose and the adapting multiplier used in a tight glucose
control protocol are better markers of nosocomial infection
risk than are summary measures of blood glucose.
Patients and Methods
Nine hundred seventy-seven patients were admitted to the
Vanderbilt University Trauma Service from October 4, 2005 to
April 2, 2006. There were 356 patients who met the study
criteria (mechanical ventilation and blood glucose concen-
tration <110 mg=dL) and were treated with the tight glucose
control protocol utilizing the computer order entry system.
Those with fewer than five glucose values or not surviving the
initial 24 h of admission were excluded (Fig. 1).
Insulin protocol
Vanderbilt University developed a computerized care
provider order entry (CPOE) system that facilitates mainte-
nance of euglycemia (blood glucose 80–110 mg=dL) using an
intravenous insulin infusion. The adjusted insulin dose is
determined by a linear equation that utilizes an adaptable
multiplier based on the glucose response from the previous
dosing period and is calculated every 2 h. The adaptability of
M to various physiologic demands throughout a patient’s
hospitalization is a key characteristic of the protocol. The in-
sulin dose (units=h) is calculated using the formula:
Dose¼M· [blood glucose (mg=dL) 60]
The M is initially set at 0.03 and can never fall below zero. The
insulin dose is altered with an adapting multiplier, which is
controlled by a set of rules (Fig. 2). The multiplier increases
and decreases in relation to the distance from the goal range of
80–110 mg=dL; i.e., if the most recent blood glucose concen-
tration is 58 mg=dL, the multiplier decreases by 0.02 whereas
if it is 77 mg=dL, the dose would be decreased by only 0.01.
The multiplier continues to be titrated until the goal range is
reached and then does not change until the blood glucose
concentration once again falls outside the range. The protocol
titration has been shown to be effective in maintaining eu-
glycemia [14, 15].
FIG. 2. Description of the insulin protocol titration, blood glucose is checked on a q 2hr basis.
FIG. 1. Study design. BS¼ blood sugar.
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On admission, all patients are started on a glucose source
consisting of intravenous dextrose (D5 or D10) to deliver
partial nutritional support (5–10 g=h) unless enteral or par-
enteral feeding is being delivered. Enteral nutritional support
is initiated as soon as the attending physician believes it to be
safe. Parenteral nutritional support is initiated on day 5 of the
patient’s intensive care unit (ICU) stay if 70% of goal nutrition
cannot be attained enterally and continued until enteral sup-
port is adequate. Nutrition goals have been established ac-
cording to published standards with 20 to 24 non-protein
kcal=kg of body weight per 24 h [16].
Blood glucose measurements are performed on protocol
by a member of the nursing staff using the SureStep Pro
(One-Touch) Professional Blood Glucose Monitoring System
(http:==www.lifescan.com=professionals=products=sspro=).
Measurements were taken at 2-h intervals except after hypo-
glycemic events (blood glucose <60 mg=dL), which trigger
a repeat measurement within 1 h. The insulin protocol pro-
duced entries that consist of a blood glucose value, multiplier
value, insulin dose, glucose source, time, and date.
Data collection
Demographic, hospital outcome, and pharmacy data were
obtained from electronic hospital records and databases. In-
formation necessary to determine the severity of illness was
obtained at admission and recorded in an institutional data-
base. Scores were calculated for the simplified Injury Severity
Score (ISS) [17]. Higher scores indicate more severe illness.
The study was approved by the Institutional Review
Boards of Vanderbilt University Medical Center. All data are
maintained in a secure, password-protected database com-
pliant with the Health Insurance Portability and Account-
ability Act. All patient information is de-identified prior to
analysis and reporting.
Outcome measures
Infections were classified according to the definitions of the
U.S. Centers for Disease Control and Prevention. Pulmonary
infection was diagnosed when a predominant organism was
isolated from an appropriately obtained culture in the setting
of purulent sputum production, a new or changing infiltrate
on chest radiography, and systemic evidence of infection.
Quantitative bronchoalveolar lavage was used exclusively
(>104 organisms=mL considered positive). Blood stream in-
fections (BSI) were diagnosed by the isolation of organisms
from a blood culture from any site, with the exception of
Staphylococcus epidermidis or other coagulase-negative staph-
ylococci, which required isolation from two sites to be evi-
dence of BSI. Criteria for urinary tract infection were isolation
of >105 organisms=mL of urine or >104 organisms=mL and
accompanying dysuria. Criteria for catheter-related infection
included isolation of 15 or more colony-forming units from
catheter tips by a semiquantitative roll plate technique in the
setting of suspected infection (systemic symptoms or local-
ized purulence). Wound infections were diagnosed clinically,
and cultures were considered positive if a pathologic organ-
ism was isolated from swab cultures. Patients were stratified
by the presence and number of positive cultures and analyzed
by both serum glucose measures and measures of insulin re-
sistance (IR)(average multiplier and average insulin infusion
rate). Secondary outcome measures were hospital length of
stay (LOS), ICU LOS, and ventilator days.
Statistical analysis
Normally distributed continuous variables were summa-
rized by reporting the mean and standard deviation and
compared using analysis of variance (ANOVA) for indepen-
dent samples. Continuous variables that were not normally
distributed were presented by reporting the median and in-
terquartile ranges (IQR) and compared using the Mann-
Whitney U test. Continuous matched data were compared
using a Wilcoxon matched pairs test. Differences in propor-
tions were compared using a chi-square or Fisher exact test. A
two-sided p value <0.05 was considered statistically signifi-




A total of 356 patients were enrolled with an overall mor-
tality rate of 13.8% (n¼ 49). On admission, 39 patients (11.0%)
had a medical history of diabetes mellitus, with 35 of the 39
(89.7%) being non-insulin dependent diabetics (NIDDM) and
the remainder having insulin-dependent diabetes (IDDM). As
Table 1. Demographics of Study Group
Age (years) 39 (IQR 24–57)
Male=female (%) 253 (71)=103 (29)






Length of stay (days) 9 (IQR 5–16)
Intensive care unit length
of stay (days)
6 (IQR 3–13)
Ventilator days 3 (IQR 1–7)
Injury Severity Score 29 13
Deaths (%) 49 (13.8)
Data presented as median and interquartile range (IQR) except as
noted.








No. (%) in range
(80–110 mg=dL)
8,178 (42.8)
No. (%) in range
(80–150 mg=dL)
15,396 (80.5)
60 mg=dL (%) 360 (1.9)
40 mg=dL (%) 48 (0.2)
9.8% of patients experienced
one hypoglycemic episode
IQR¼ interquartile range.
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a group, the mean age was 39 (IQR 24–57), the mean ISS was
29 13, and the mean Revised Trauma Score (RTS) was
7.8 3.7. The median glucose concentration for the entire
group was 121 22 mg=dL. There were 360 episodes of hy-
poglycemia (60 mg=dL) documented in 4,918 patient-days
and 19,126 glucose values with corresponding insulin indices
available for all (Tables 1 and 2).
Blood glucose control
Patients were divided into groups according to the pres-
ence or absence of a nosocomial infection during their hos-
pitalization. The admission blood glucose concentration was
significantly higher in the group not experiencing a positive
culture (150 mg=dL for culture-positive patients and
163 mg=dL for those without a positive culture; p¼ 0.01). The
median blood glucose concentration was statistically different
between the groups (113 mg=dL for culture-positive and
118 mg=dL for culture-negative; p 0.001). The median in-
sulin dose was significantly higher in the culture-positive
groups (3.7 U=h vs. 2.8 U=h; p 0.001). The mean multiplier
also was higher in culture-positive patients (0.071) than in
survivors (0.047) (p 0.001).
Infective complications
During the six-month study period, 356 patients were
placed on the tight glycemic control protocol. Of these, 101
patients had 192 positive cultures. Patients who had a positive
culture had demographic characteristics similar to the pa-
tients who did not experience post-traumatic sepsis, with only
the ISS being significantly different (Table 3). Analysis of the
number of positive cultures and median insulin rate and
glucose measures are shown in Table 4.
Patients were then divided into groups on the basis of the
number of positive cultures. Patients with multiple positive
cultures required significantly more insulin and had a higher
adapting multiplier but actually had lower median glucose
values than the patients experiencing none or one positive
culture (Tables 5 and 6). Logistic regression showed insulin
dose (odds ratio [OR] 2.1; 95% confidence interval [CI] 1.6, 3.0;
p 0.001) and the adapting multiplier as independent pre-
dictors of a positive culture among other factors associated
with nosocomial infection (Table 7).
The temporal relation of glucose control and infection was
examined by taking the 149 patients having cultures and di-
viding them into those with a positive culture (Table 8) and
those who had a negative culture (Table 9). We then examined
measures of glucose control in the 24 h preceding and fol-
lowing culture.
Discussion
Tight glycemic control has become the gold standard in
critical care settings around the world. Initial acceptance was
based largely on a single-institution trial in a predominately
cardiac population [18]. Despite this narrow study, the results
have been applied to multiple critically ill populations, in-
cluding trauma victims. Within these other studies, patients
randomized to tight glucose control demonstrated fewer in-
fective complications.
Many clinicians have observed that hyperglycemia usually
precedes infections. In an era of tight glucose control where
blood glucose is manipulated artificially, the ability to dis-
tinguish patients on the basis of this marker is diminished.
Aggressive adoption of euglycemia protocols has resulted in
infected patients having median blood glucose values similar
to those of non-infected patients. As a result, additional
measures of glucose control are needed to stratify patients.
We sought to identify patients who are resistant to tight
glucose control by requiring higher insulin doses and there-
fore having a higher adapting multiplier. Protocols are be-
coming more sophisticated and adapt rapidly to changes in a
patient’s physiology. Blood glucose is kept within a goal
range, whereas insulin doses change significantly. We were
able to document those patients with positive cultures, and
patients with multiple positive cultures required significantly
more insulin over their hospital stays.
Table 4. Outcome Measures in Patients Who Had One Positive Culture and Those Who Did Not
Positive culture (n¼ 101) No positive cultures (n¼ 255) P value
Insulin rate (units=h) 3.7 (2.8–5.5) 2.8 (2.0–3.9) <0.001
Multiplier 0.071 (0.053–0.100) 0.047 (0.037–0.063) <0.001
Admitting glucose concentration (mg=dL) 150.0 (128–186) 163 (137–203) 0.013
Median blood glucose (mg=dL) 113.0 (107–119) 118 (110–128) 0.001
Data presented as median (interquartile range).
Table 3. Comparison of Demographic Features of Patients With and Without a Positive Culture
Culture positive (n¼ 101) No positive culture (n¼ 255) P value
Age (years) 42 20 43 21 0.92
Male sex (%) 76 (75.2) 177 (69.4) 0.27
Body mass index (kg=m2) 27.3 .7.0 26.2 6.0 0.41
Injury Severity Score 34.2 12.0 26.6 12.6 <0.001
Diabetes (%) 9 (8.7) 26 (10.4) 0.84
Data presented as mean standard deviation except as noted.
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The hyperglycemic state that occurs during critical illness
is, to a significant degree, related to the development of in-
sulin resistance induced by elevated stress hormone and cy-
tokine response [19–21]. This stress response results in altered
glucose metabolism in both the liver (non-reversible with in-
sulin therapy) and the skeletal muscle (reversible with insulin
therapy) [22–26]. Insulin resistance is defined as unrespon-
siveness to the normal effects of insulin and occurs when the
metabolic features of insulin deficiency (hyperglycemia, in-
creased lipolysis, and protein catabolism) are observed in the
presence of normal or raised concentrations of plasma insulin
[27].
In this study, we used the algorithm multiplier as a bio-
marker for insulin resistance. Reliable markers of insulin re-
sistance have been difficult to identify, making the relation
between insulin and blood glucose challenging. These mark-
ers of insulin resistance have focused on complex cytokine
and genetic expression that make bedside evaluation difficult
[28–30]. A higher multiplier, translating into a patient’s re-
ceiving larger insulin doses to remain within the goal range,
was associated with more infections. We have previously
shown that a higher multiplier also is associated with death
[31]. We have demonstrated also that the multiplier is highly
variable across the surgically ill population, as well as during
a patient’s admission. This variability is a reflection of an in-
dividual’s unpredictable response to tight insulin control. It
also frames the view that the importance of a patient’s re-
sponse to the initiation of tight glucose control can be more
predictive than the absolute numbers (mean blood glucose
concentration) while on protocol.
In univariable analysis, the patients who did not have a
positive culture during the admission actually had higher
median glucose values. This likely was attributable to their
shorter ICU stays and shorter time to reach the steady state of
glucose control. In contrast, multivariable analysis showed
that lower median glucose values over a patient’s hospitali-
zation decreased the chances of nosocomial infection. The
strongest predictor of infection was the insulin dose, with
every additional unit a patient required conferring more than
a two-fold increase in the likelihood of a positive culture. This
relation was present even when controlling for LOS and se-
verity of injury at presentation.
We attempted to demonstrate a temporal relation between
markers of insulin resistance and a positive culture. We found
that the blood glucose concentration was nearly identical
before and after cultures were obtained regardless of whether
the culture was positive or negative. We had expected this
result, given the effectiveness of the glucose protocol. Nega-
tive cultures had no significant differences between pre- and
post-insulin resistance markers, as expected. We were unable
to demonstrate a significant increase in the insulin dose pre-
ceding a positive culture. This may have been a by-product
of the protocol, with only small changes in the insulin dose
occurring every 2 h. It may also be a result of the anti-
inflammatory actions of insulin itself. Finally, it may be that
insulin resistance does not develop rapidly enough to be
documented by examining only 24-h windows. The patients
who expressed increased insulin resistance over their entire
hospital course did indeed have a higher incidence of positive
cultures, but we were unable to document a temporal relation






(n¼ 44) P value
Insulin rate (units=h) 2.8 (2.0–4.0) 3.5 (2.8–5.5) 3.6 (2.6–5.5) <0.001
Multiplier 0.047 (0.037–0.064) 0.071 (0.051–0.092) 0.070 (0.053–0.102) <0.001
Admitting glucose concentration (mg=dL) 157 (134–198) 158 (134–197) 133 (112–160) 0.001
Median blood glucose concentration (mg=dL) 118 (109–129) 115 (108–121) 112 (107–119) 0.001
Data presented as median (interquartile range) unless otherwise noted.
Table 7. Regression for Predictors of Positive
Culture Over the Hospitalization
OR 95% CI P value
Blood glucose concentration
(mg=dL)
0.904 0.858, 0.951 <0.001
Insulin rate (units=h) 2.144 1.554, 2.957 <0.001
Injury Severity Score 1.034 1.002, 1.067 0.04
Age (years) 0.994 0.977, 1.011 0.461
Admission glucose
concentration (mg=dL)
0.999 0.993, 1.004 0.640
Intensive care unit length
of stay (days)
1.149 1.086, 1.216 <0.001
CI¼ confidence interval; OR¼odds ratio.






(n¼ 44) P value
Median Injury Severity Score 25 (16–34) 34 (25–42) 34 (25–42) 0.355
Received vasopressor (%) 159 (62.4) 43 (75.4%) 36 (81.8) 0.004
Hospital days (range) 7 (4–12) 17 (12–25) 24 (16–42) <0.001
Intensive care unit days (range) 4 (2–8) 14 (9–20) 17 (12–41) <0.001
Ventilator days (range) 2 (1–4) 9 (6–14) 14 (6–26) <0.001
Deaths (%) 41 (16.1) 5 (8.8) 3 (6.8) 0.05
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between measures of glucose control in the 24 h surrounding
acquisition of cultures.
Our prior work in a more diverse critical care population
showed that patients’ responses to tight glucose control are
variable, and the degree to which a patient manifests insulin
resistance may be predictive of outcome. This variability of
response emphasizes the point that a protocol for tight insulin
control must be able to adapt in real time to patient physi-
ology. It also illustrates that the response to exogenous insulin
is heterogeneous and likely an interaction of multiple geno-
typic and phenotypic factors that are still being established
[31]. These data support the view that the individual patient’s
response to attempts to control the hyperglycemic response
can itself be an important predictor of outcome.
One limitation of this study is our inability to control for the
amount of glucose given to these patients except that they
were all on a rigid nutritional protocol. Basic science research
indicates that nondiabetic hospitalized patients who receive
dextrose solutions at rates >4 g=kg=min (e.g., total parenteral
nutrition [TPN] solutions) have a 50% chance of developing
hyperglycemia [32]. There were 20 patients of the 356 who
received TPN during their admissions. The patients with a
positive culture did receive more TPN than those who never
had a positive culture (16% vs. 1.6%; p 0.001). When ex-
cluding the patients on TPN from analysis, the insulin dose
remains significantly elevated in the patients with a positive
culture (3.5 units=h vs. 2.8 units=h; p< 0.001); this holds true
for the multiplier as well (0.070 vs. 0.464; p< 0.001). This
finding supports the idea that TPN use is correlated with a
higher infection risk, but does not explain all the increase in
risk associated with insulin resistance. We are unable to give
the exact caloric input the patients received in this retrospec-
tive evaluation. This limitation is ubiquitous to this type of
research, with multiple factors, including narcotics [33], an-
esthesia [34], and patient core temperature [35], all affecting
glucose metabolism. It is challenging to perform tight glucose
control in a vacuum, much less the complex environment of a
functioning intensive care unit. We must rely on the fact that
the patients were cared for according to a strict protocol using
established goals and were exposed to a consistent practice
pattern.
In this study, we have shown that infection risk is associ-
ated with resistance to the initiation of tight glucose control
and a need for higher doses of insulin to maintain euglycemia.
Patients in the positive-culture group required more insulin to
stay within the desired range despite similar demographic
factors. Although the retrospective nature of this paper does
not permit establishing insulin resistance as the cause of the
increase in morbidity, these data do suggest that insulin re-
sistance is more pronounced in patients who have multiple
positive cultures. Controlling hyperglycemia can decrease
infection [18], but there still exists a group with a higher risk of
infection. Early identification of these patients can lead to
greater vigilance. These patients’ expression of insulin resis-
tance helps better define a population that has morbidity and
mortality rates higher than their injuries would predict. Re-
cognition of the patients at risk must serve as a warning until a
time when augmentation of the underlying insulin resistance
can be addressed pharmaceutically or with the aid of genetic
manipulation.
Conclusions
In an era in which tight glucose control is considered
standard, we continue to strive to evaluate how individual
patients respond to attempts to maintain euglycemia. Insulin
resistance quantified by hourly insulin dose and median
multiplier confers a higher risk of systemic nosocomial in-
fection. Patients with positive cultures actually had lower
admission and median blood glucose values over their ICU
stays, highlighting the lesser value of this measure as a pre-
dictor of outcome in the setting of tight glucose control. A
greater insulin requirement suggesting insulin resistance can
be used as a marker for a higher risk of nosocomial infection.
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